PL EN


Preferences help
enabled [disable] Abstract
Number of results
2003 | 50 | 3 | 625-645
Article title

Structure and functions of tumor necrosis factor-α converting enzyme.

Content
Title variants
Languages of publication
EN
Abstracts
EN
Tumor necrosis factor-α converting enzyme (TACE) is the first described and best characterized secretase. In this review the structure and the possible roles for TACE are summarized. The substrate specificity and the regulation of TACE activity as well as redundancy and possible cooperations of distinct secretases are also discussed.
Keywords
Publisher

Year
Volume
50
Issue
3
Pages
625-645
Physical description
Dates
published
2003
received
2003-05-30
revised
2003-07-28
accepted
2003-08-12
Contributors
  • Department of Cell Biochemistry, Faculty of Biotechnology, Jagiellonian University, Kraków, Poland
  • Department of Cell Biochemistry, Faculty of Biotechnology, Jagiellonian University, Kraków, Poland
author
  • Department of Cell Biochemistry, Faculty of Biotechnology, Jagiellonian University, Kraków, Poland
References
  • Aderka D. (1996) The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev.; 7: 231-40.
  • Aggarwal BB, Samanta A, Feldmann M. (2001) TNFα. In Cytokine reference, Durum SK, Hirano T, Vilcek J, Nicola NA. eds, pp 413-34, Academic Press, London.
  • Althoff K, Reddy P, Voltz N, Rose-John S, Mullberg J. (2000) Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins. Eur J Biochem.; 267: 2624-31.
  • Althoff K, Mullberg J, Aasland D, Voltz N, Kallen K, Grotzinger J, Rose-John S. (2001) Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins. Biochem J.; 353: 663-72.
  • Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, Stephens PE, Shelley C, Hutton M, Knauper V, Docherty AJ, Murphy G. (1998) TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett.; 435: 39-44.
  • Aplin JD, Meseguer M, Simon C, Ortiz ME, Croxatto H, Jones CJ. (2001) MUC1, glycans and the cell-surface barrier to embryo implantation. Biochem Soc Trans.; 29: 153-6.
  • Arribas J, Borroto A. (2002) Protein ectodomain shedding. Chem Rev.; 102: 4627-38.
  • Arribas J, Lopez-Casillas F, Masaque J. (1997) Role of the juxtamembrane domains of the transforming growth factor-alpha precursor and the beta-amyloid precursor protein in regulated ectodomain shedding. J Biol Chem.; 272: 17160-5.
  • Artavanis-Tsakonas S, Rand MD, Lake RJ. (1999) Notch signaling: cell fate control and signal integration in development. Science.; 284: 770-6.
  • Asai M, Hattori C, Szabo B, Sasagawa N, Maruyama K, Tanuma S, Ishiura S. (2003) Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase. Biochem Biophys Res Commun.; 301: 231-5.
  • Baker AH, Edwards DR, Murphy G. (2002) Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci.; 115: 3719-27.
  • Beck G, Bottomley G, Bradshaw D, Brewster M, Broadhurst M, Devos R, Hill C, Johnson W, Kim HJ, Kirtland S, Kneer J, Lad N, Mackenzie R, Martin R, Nixon J, Price G, Rodwell A, Rose F, Tang JP, Walter DS, Wilson K, Worth E. (2002) (E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2'-isobutyl-2'-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a selective and orally active inhibitor of tumor necrosis factor-α convertase. J Pharmacol Exp Ther.; 302: 390-6.
  • Bereta M, Bereta J, Cohen S, Cohen MC. (1992) Low density lipoprotein inhibits accumulation of nitrites in murine brain endothelial cell cultures. Biochem Biophys Res Commun.; 186: 315-20.
  • Bereta J, Bereta M, Cohen S, Cohen MC. (1993) Regulation of VCAM-1 expression and involvement in cell adhesion to murine microvascular endothelium. Cell Immunol.; 147: 313-30.
  • Berra E, Milanini J, Richard DE, Le Gall M, Vinals F, Gothie E, Roux D, Pages G, Pouyssegur J. (2000) Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. Biochem Pharmacol.; 60: 1171-8.
  • Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature.; 385: 729-33.
  • Borrell-Pages M, Rojo F, Albanell J, Baselga J, Arribas J. (2003) TACE is required for the activation of the EGFR by TGF-alpha in tumors. EMBO J.; 22: 1114-24.
  • Borroto A, Ruiz-Paz S, Villanueva De La Torre T, Borrell-Pages M, Merlos-Suarez A, Pandiella A, Blobel CP, Baselga J, Arribas J. (2003) Impaired trafficking and activation of TACE in cell mutants defective in protein ectodomain shedding. J Biol Chem.; 278: 25933-9.
  • Brakebusch C, Varfolomeev EE, Batkin M, Wallach D. (1994) Structural requirements for inducible shedding of the p55 tumor necrosis factor receptor. J Biol Chem.; 269: 32488-96.
  • Bray S. (2000) Notch. Curr Biol.; 10: R433-5.
  • Brou C, Logeat F, Gupta N, Bessia C, LeBail O, Doedens JR, Cumano A, Roux P, Black RA, Israel A. (2000) A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell.; 5: 207-16.
  • Bugno M, Witek B, Bereta J, Bereta M, Edwards DR, Kordula T. (1999) Reprogramming of TIMP-1 and TIMP-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to proinflammatory cytokines. FEBS Lett.; 448: 9-14.
  • Buxbaum JD, Koo EH, Greengard P. (1993) Protein phosphorylation inhibits production of Alzheimer amyloid beta/A4 peptide. Proc Natl Acad Sci U S A.; 90: 9195-8.
  • Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, Peschon JJ, Johnson RS, Castner BJ, Cerretti DP, Black RA. (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem.; 273: 27765-7.
  • Cabrera N, Diaz-Rodriguez E, Becker E, Martin-Zanca D, Pandiella A. (1996) TrkA receptor ectodomain cleavage generates a tyrosine-phosphorylated cell-associated fragment. J Cell Biol.; 132: 427-36.
  • Cerretti DP, Poindexter K, Castner BJ, Means G, Copeland NG, Gilbert DJ, Jenkins NA, Black RA, Nelson N. (1999) Characterization of the cDNA and gene for mouse tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and its location to mouse chromosome 12 and human chromosome 2p25. Cytokine.; 11: 541-51.
  • Chesneau V, Becherer D, Zheng Y, Erdjument-Bromage H, Tempst P, Blobel CP. (2003) Catalytic properties of ADAM19. J Biol Chem.; 278: 22331-40.
  • Clarke HR, Wolfson MF, Rauch CT, Castner BJ, Huang CP, Gerhart MJ, Johnson RS, Cerretti DP, Paxton RJ, Price VL, Black RA. (1998) Expression and purification of correctly processed, active human TACE catalytic domain in Saccharomyces cerevisiae. Protein Expr Purif.; 13: 104-10.
  • Cotter R, Williams C, Ryan L, Erichsen D, Lopez A, Peng H, Zheng J. (2002) Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia. J Neurovirol.; 8: 585-98.
  • Cybulsky MI, Hegele RA. (2003) The fractalkine receptor CX3CR1 is a key mediator of atherogenesis. J Clin Invest.; 111: 1118-20.
  • Diaz-Rodriguez E, Cabrera N, Esparis-Ogando A, Montero JC, Pandiella A. (1999) Cleavage of the TrkA neurotrophin receptor by multiple metalloproteases generates signalling-competent truncated forms. Eur J Neurosci.; 11: 1421-30.
  • Diaz-Rodriguez E, Montero JC, Esparis-Ogando A, Yuste L, Pandiella A. (2002) Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. Mol Biol Cell.; 13: 2031-44.
  • Ding T, Li L, Zhu K, Huang W, Yang Y. (2001) Relationship between the increase of secretion of sTNF alpha induced by lipopolysaccharides and the enhanced expression of TACE mRNA in HL-60 cells and adhesive cells from human spleen. J Tongji Med Univ.; 21: 265-8, 279.
  • Doedens JR, Black RA. (2000) Stimulation-induced down-regulation of tumor necrosis factor-alpha converting enzyme. J Biol Chem.; 275: 14598-607.
  • Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP. (2002) Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships. J Med Chem.; 45: 4954-7.
  • Elenius K, Corfas G, Paul S, Choi CJ, Rio C, Plowman GD, Klagsbrun M. (1997) A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester. J Biol Chem.; 272: 26761-8.
  • Fan H, Derynck R. (1999) Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades. EMBO J.; 18: 6962-72.
  • Fan H, Turck CW, Derynck R. (2003) Characterization of growth factor-induced serine phosphorylation of tumor necrosis factor-alpha converting enzyme and of an alternatively translated polypeptide. J Biol Chem.; 278: 18617-27.
  • Ferri LE, Pascual J, Seely AJ, Chaudhury P, Christou NV. (2002) Soluble L-selectin attenuates tumor necrosis factor-alpha-mediated leukocyte adherence and vascular permeability: a protective role for elevated soluble L-selectin in sepsis. Crit Care Med.; 30: 1842-7.
  • Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, Dempsey PJ, Raines EW. (2001) Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem.; 276: 37993-8001.
  • Giraudo E, Primo L, Audero E, Gerber HP, Koolwijk P, Soker S, Klagsbrun M, Ferrara N, Bussolino F. (1998) Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. J Biol Chem.; 273: 22128-35.
  • Gomez-Gaviro MV, Gonzalez-Alvaro I, Dominguez-Jimenez C, Peschon J, Black RA, Sanchez-Madrid F, Diaz-Gonzalez F. (2002) Structure-function relationship and role of tumor necrosis factor-alpha-converting enzyme in the down-regulation of L-selectin by non-steroidal anti-inflammatory drugs. J Biol Chem.; 277: 38212-21.
  • Greaves DR, Schall TJ. (2001) Fractalkine. In Cytokine reference, Durum SK, Hirano T, Vilcek J, Nicola NA. eds, pp 413-34, Academic Press, London.
  • Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, et al. (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell.; 83: 793-802.
  • Haro H, Crawford HC, Fingleton B, Shinomiya K, Spengler DM, Matrisian LM. (2000) Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. J Clin Invest.; 105: 143-50.
  • Hehlgans T, Mannel DN. (2002) The TNF-TNF receptor system. Biol Chem.; 383: 1581-5.
  • Hinkle CL, Mohan MJ, Lin P, Yeung N, Rasmussen F, Milla ME, Moss ML. (2003) Multiple metalloproteinases process protransforming growth factor-alpha (proTGF-alpha). Biochemistry.; 42: 2127-36.
  • Hotoda N, Koike H, Sasagawa N, Ishiura S. (2002) A secreted form of human ADAM9 has an alpha-secretase activity for APP. Biochem Biophys Res Commun.; 293: 800-5.
  • Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K, Hartmann D, Fahrenholz F, Postina R, Matthews V, Kallen KJ, Rose-John S, Ludwig A. (2003) The disintegrin-like metalloproteinase ADAM 10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood.; 102: 1186-95.
  • Imaizumi T, Itaya H, Fujita K, Kudoh D, Kudoh S, Mori K, Fujimoto K, Matsumiya T, Yoshida H, Satoh K. (2000) Expression of tumor necrosis factor-alpha in cultured human endothelial cells stimulated with lipopolysaccharide or interleukin-1alpha. Arterioscler Thromb Vasc Biol.; 20: 410-5.
  • Itai T, Tanaka M, Nagata S. (2001) Processing of tumor necrosis factor by the membrane-bound TNF-alpha-converting enzyme, but not its truncated soluble form. Eur J Biochem.; 268: 2074-82.
  • Izumi Y, Hirata M, Hasuwa H, Iwamoto R, Umata T, Miyado K, Tamai Y, Kurisaki T, Sehara-Fujisawa A, Ohno S, Mekada E. (1998) A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J.; 17: 7260-72.
  • Josien R, Wong BR, Li HL, Steinman RM, Choi Y. (1999) TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol.; 162: 2562-8.
  • Josien R, Li HL, Ingulli E, Sarma S, Wong BR, Vologodskaia M, Steinman RM, Choi Y. (2000) TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J Exp Med.; 191: 495-502.
  • Kataoka M, Yoshiyama K, Matsuura K, Hijiya N, Higuchi Y, Yamamoto S. (1997) Structure of the murine CD156 gene, characterization of its promoter, and chromosomal location. J Biol Chem.; 272: 18209-15.
  • Kiessling LL, Gordon EJ. (1998) Transforming the cell surface through proteolysis. Chem Biol.; 5: R49-62.
  • Koike H, Tomioka S, Sorimachi H, Saido TC, Maruyama K, Okuyama A, Fujisawa-Sehara A, Ohno S, Suzuki K, Ishiura S. (1999) Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. Biochem J.; 343: 371-5.
  • LaVoie MJ, Selkoe DJ. (2003) The Notch ligands, jagged and delta, are sequentially processed by α-secretase and presenilin/γ-secretase and release signaling fragments. J Biol Chem.; 278: 34427-37
  • Lee MH, Verma V, Maskos K, Nath D, Knauper V, Dodds P, Amour A, Murphy G. (2002) Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzyme. Biochem J.; 364: 227-34.
  • Lee MH, Dodds P, Verma V, Maskos K, Knauper V, Murphy GR. (2003) Tailoring tissue inhibitor of metalloproteinases-3 to overcome the weakening effects of the cysteine-rich domains of tumour necrosis factor-alpha converting enzyme. Biochem J.; 371: 369-76.
  • Lopez-Perez E, Zhang Y, Frank SJ, Creemers J, Seidah N, Checler F. (2001) Constitutive alpha-secretase cleavage of the beta-amyloid precursor protein in the furin-deficient LoVo cell line: involvement of the pro-hormone convertase 7 and the disintegrin metalloprotease ADAM10. J Neurochem.; 76: 1532-9.
  • Lum L, Wong BR, Josien R, Becherer JD, Erdjument-Bromage H, Schlondorff J, Tempst P, Choi Y, Blobel CP. (1999) Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem.; 274: 13613-8.
  • MacEwan DJ. (2002) TNF receptor subtype signalling: differences and cellular consequences. Cell Signal.; 14: 477-92.
  • Madge LA, Pober JS. (2001) TNF signaling in vascular endothelial cells. Exp Mol Pathol.; 70: 317-25.
  • Majka S, McGuire PG, Das A. (2002) Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization. Invest Ophthalmol Vis Sci.; 43: 260-6.
  • Maskos K, Fernandez-Catalan C, Huber R, Bourenkov GP, Bartunik H, Ellestad GA, Reddy P, Wolfson MF, Rauch CT, Castner BJ, Davis R, Clarke HR, Petersen M, Fitzner JN, Cerretti DP, March CJ, Paxton RJ, Black RA, Bode W. (1998) Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc Natl Acad Sci U S A.; 95: 3408-12.
  • McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, Mansfield E, Gadina M, Karenko L, Pettersson T, McCarthy J, Frucht DM, Aringer M, Torosyan Y, Teppo AM, Wilson M, Karaarslan HM, Wan Y, Todd I, Wood G, Schlimgen R, Kumarajeewa TR, Cooper SM, Vella JP, Kastner DL, et al. (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell.; 97: 133-44.
  • Merlos-Suarez A, Ruiz-Paz S, Baselga J, Arribas J. (2001) Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme. J Biol Chem.; 276: 48510-7.
  • Migaki GI, Kahn J, Kishimoto TK. (1995) Mutational analysis of the membrane-proximal cleavage site of L-selectin: relaxed sequence specificity surrounding the cleavage site. J Exp Med.; 182: 549-57.
  • Milla ME, Leesnitzer MA, Moss ML, Clay WC, Carter HL, Miller AB, Su JL, Lambert MH, Willard DH, Sheeley DM, Kost TA, Burkhart W, Moyer M, Blackburn RK, Pahel GL, Mitchell JL, Hoffman CR, Becherer JD. (1999) Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE). J Biol Chem.; 274: 30563-70.
  • Mizui Y, Yamazaki K, Sagane K, Tanaka I. (1999) cDNA cloning of mouse tumor necrosis factor-alpha converting enzyme (TACE) and partial analysis of its promoter. Gene.; 233: 67-74.
  • Modur V, Li Y, Zimmerman GA, Prescott SM, McIntyre TM. (1997) Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J Clin Invest.; 100: 2752-6.
  • Mohan MJ, Seaton T, Mitchell J, Howe A, Blackburn K, Burkhart W, Moyer M, Patel I, Waitt GM, Becherer JD, Moss ML, Milla ME. (2002) The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity. Biochemistry.; 41: 9462-9.
  • Montero JC, Yuste L, Diaz-Rodriguez E, Esparis-Ogando A, Pandiella A. (2000) Differential shedding of transmembrane neuregulin isoforms by the tumor necrosis factor-alpha-converting enzyme. Mol Cell Neurosci.; 16: 631-48.
  • Montero JC, Yuste L, Diaz-Rodriguez E, Esparis-Ogando A, Pandiella A. (2002) Mitogen-activated protein kinase-dependent and -independent routes control shedding of transmembrane growth factors through multiple secretases. Biochem J.; 363: 211-21.
  • Moss ML, Lambert MH. (2002) Shedding of membrane proteins by ADAM family proteases. Essays Biochem.; 38: 141-53.
  • Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Becherer JD, et al. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature.; 385: 733-6.
  • Moss ML, White JM, Lambert MH, Andrews RC. (2001) TACE and other ADAM proteases as targets for drug discovery. Drug Discov Today.; 6: 417-26.
  • Mueller C, Corazza N, Trachsel-Loseth S, Eugster HP, Buhler-Jungo M, Brunner T, Imboden MA. (1999) Noncleavable transmembrane mouse tumor necrosis factor-alpha (TNFalpha) mediates effects distinct from those of wild-type TNFalpha in vitro and in vivo. J Biol Chem.; 274: 38112-8.
  • Mullberg J, Oberthur W, Lottspeich F, Mehl E, Dittrich E, Graeve L, Heinrich PC, Rose-John S. (1994) The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site. J Immunol.; 152: 4958-68.
  • Nelson KK, Schlondorff J, Blobel CP. (1999) Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta. Biochem J.; 343: 673-80.
  • Olson GE, Winfrey VP, Matrisian PE, NagDas SK, Hoffman LH. (1998) Blastocyst-dependent upregulation of metalloproteinase/disintegrin MDC9 expression in rabbit endometrium. Cell Tissue Res.; 293: 489-98.
  • Patel IR, Attur MG, Patel RN, Stuchin SA, Abagyan RA, Abramson SB, Amin AR. (1998) TNF-alpha convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-alpha. J Immunol.; 160: 4570-9.
  • Peiretti F, Canault M, Deprez-Beauclair P, Berthet V, Bonardo B, Juhan-Vague I, Nalbone G. (2003a) Intracellular maturation and transport of tumor necrosis factor alpha converting enzyme. Exp Cell Res.; 285: 278-85.
  • Peiretti F, Deprez-Beauclair P, Bonardo B, Aubert H, Juhan-Vague I, Nalbone G. (2003b) Identification of SAP97 as an intracellular binding partner of TACE. J Cell Sci.; 116: 1949-57.
  • Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, Boyce RW, Nelson N, Kozlosky CJ, Wolfson MF, Rauch CT, Cerretti DP, Paxton RJ, March CJ, Black RA. (1998) An essential role for ectodomain shedding in mammalian development. Science.; 282: 1281-4.
  • Primakoff P, Myles DG. (2000) The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet.; 16: 83-7.
  • Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC. (2001) Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE). J Med Chem.; 44: 4252-67.
  • Reddy P, Slack JL, Davis R, Cerretti DP, Kozlosky CJ, Blanton RA, Shows D, Peschon JJ, Black RA. (2000) Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem.; 275: 14608-14.
  • Rio C, Buxbaum JD, Peschon JJ, Corfas G. (2000) Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4. J Biol Chem.; 275: 10379-87.
  • Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, van Hinsbergh V, Sozzani S, Bussolino F, Poli V, Ciliberto G, Mantovani A. (1997) Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity.; 6: 315-25.
  • Rose-John S, Heinrich PC. (1994) Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J.; 300: 281-90.
  • Rosendahl MS, Ko SC, Long DL, Brewer MT, Rosenzweig B, Hedl E, Anderson L, Pyle SM, Moreland J, Meyers MA, Kohno T, Lyons D, Lichenstein HS. (1997) Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases. J Biol Chem.; 272: 24588-93.
  • Rovida E, Paccagnini A, Del Rosso M, Peschon J, Dello Sbarba P. (2001) TNF-alpha-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation. J Immunol.; 166: 1583-9.
  • Sanceau J, Kaisho T, Hirano T, Wietzerbin J. (1995) Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors. J Biol Chem.; 270: 27920-31.
  • Schlondorff J, Becherer JD, Blobel CP. (2000) Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE). Biochem J.; 347: 131-8.
  • Seidelin JB, Nielsen OH, Strom J. (2002) Soluble L-selectin levels predict survival in sepsis. Intensive Care Med.; 28: 1613-8.
  • Skovronsky DM, Moore DB, Milla ME, Doms RW, Lee VM. (2000) Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network. J Biol Chem.; 275: 2568-75.
  • Skovronsky DM, Fath S, Lee VM, Milla ME. (2001) Neuronal localization of the TNFalpha converting enzyme (TACE) in brain tissue and its correlation to amyloid plaques. J Neurobiol.; 49: 40-6.
  • Stamenkovic I. (1995) The L-selectin adhesion system. Curr Opin Hematol.; 2: 68-75.
  • Sunnarborg SW, Hinkle CL, Stevenson M, Russell WE, Raska CS, Peschon JJ, Castner BJ, Gerhart MJ, Paxton RJ, Black RA, Lee DC. (2002) Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J Biol Chem.; 277: 12838-45.
  • Symons JA, Young PR, Duff GW. (1995) Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. Proc Natl Acad Sci U S A.; 92: 1714-8.
  • Tang P, Hung MC, Klostergaard J. (1996) Length of the linking domain of human pro-tumor necrosis factor determines the cleavage processing. Biochemistry.; 35: 8226-33.
  • Thathiah A, Blobel CP, Carson DD. (2003) Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding. J Biol Chem.; 278: 3386-94.
  • Tsou CL, Haskell CA, Charo IF. (2001) Tumor necrosis factor-alpha-converting enzyme mediates the inducible cleavage of fractalkine. J Biol Chem.; 276: 44622-6.
  • Turner AJ, Hooper NM. (1999) Role for ADAM-family proteinases as membrane protein secretases. Biochem Soc Trans.; 27: 255-9.
  • Van Wart HE, Birkedal-Hansen H. (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A.; 87: 5578-82.
  • Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B, Grassi J, Lopez-Perez E, Checler F. (2001) The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem.; 276: 37743-6.
  • Wong BR, Josien R, Choi Y. (1999) TRANCE is a TNF family member that regulates dendritic cell and osteoclast function. J Leukoc Biol.; 65: 715-24.
  • Yamamoto S, Higuchi Y, Yoshiyama K, Shimizu E, Kataoka M, Hijiya N, Matsuura K. (1999) ADAM family proteins in the immune system. Immunol Today.; 20: 278-84.
  • Yan GZ, Ziff EB. (1997) Nerve growth factor induces transcription of the p21 WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor. J Neurosci.; 17: 6122-32.
  • Zhang Y, Jiang J, Black RA, Baumann G, Frank SJ. (2000) Tumor necrosis factor-alpha converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: the metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation. Endocrinology.; 141: 4342-8.
  • Zhang Z, Oliver P, Lancaster Jr JR, Schwarzenberger PO, Joshi MS, Cork J, Kolls JK. (2001) Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate. FASEB J.; 15: 303-5.
  • Zhao J, Chen H, Peschon JJ, Shi W, Zhang Y, Frank SJ, Warburton D. (2001) Pulmonary hypoplasia in mice lacking tumor necrosis factor-alpha converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis. Dev Biol.; 232: 204-18.
  • Zheng Y, Schlondorff J, Blobel CP. (2002) Evidence for regulation of the tumor necrosis factor alpha-convertase (TACE) by protein-tyrosine phosphatase PTPH1. J Biol Chem.; 277: 42463-70.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.bwnjournal-article-abpv50i3p625kz
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.